Russell Investments Group, Ltd. Cidara Therapeutics, Inc. Transaction History

Russell Investments Group, Ltd.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 10, 2021	BUY	$2.06 - $3.01 $35,226 - $51,470	17,100 New	17,100 $45,000
Q2 2020 Aug 05, 2020	SELL	$2.39 - $4.0 $147,417 - $246,724	-61,681 Closed	0 $0
Q1 2020 May 06, 2020	BUY	$1.74 - $4.26 $91,095 - $223,028	52,354 Added 561.32%	61,681 $151,000
Q4 2019 Jan 29, 2020	BUY	$1.77 - $3.84 $16,508 - $35,815	9,327 New	9,327 $34,000
Q4 2018 Feb 11, 2019	SELL	$2.1 - $4.5 $15,960 - $34,200	-7,600 Closed	0 $0
Q3 2018 Oct 26, 2018	SELL	$3.7 - $5.25 $1,110 - $1,575	-300 Reduced 3.8%	7,600 $33,000
Q2 2018 Aug 08, 2018	SELL	$3.75 - $6.05 $55,500 - $89,540	-14,800 Reduced 65.2%	7,900 $41,000
Q4 2017 Feb 06, 2018	BUY	$6.35 - $8.75 $89,535 - $123,375	14,100 Added 163.95%	22,700 $157,000
Q3 2017 Nov 07, 2017	BUY	$5.75 - $8.1 $49,450 - $69,660	8,600	8,600 $70,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.43B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.